Search results
Found 16149 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
Psychiatry Annual Report 2023
Psychiatry annual report 2-23 - read a fully accessible version of the text below
Psychosocial assessment following self-harm
Psychosocial assessment following self-harm: a clinician's guide
PSYCHOSOCIAL assessment following self-harm Clinician's guide.pdf (916 KB)